These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 35782986

  • 1. Vitamin D receptor (VDR) contributes to the development of hypercalciuria by sensitizing VDR target genes to vitamin D in a genetic hypercalciuric stone-forming (GHS) rat model.
    Guo S, Chia W, Wang H, Bushinsky DA, Zhong B, Favus MJ.
    Genes Dis; 2022 May; 9(3):797-806. PubMed ID: 35782986
    [Abstract] [Full Text] [Related]

  • 2. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
    Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ.
    J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616
    [Abstract] [Full Text] [Related]

  • 3. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
    Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ.
    J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
    [Abstract] [Full Text] [Related]

  • 4. Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats.
    Xi QL, Wang SG, Ye ZQ, Zhu ZW, Li C, Bai J, Yu X, Liu JH.
    Urology; 2011 Dec; 78(6):1442.e1-7. PubMed ID: 22137721
    [Abstract] [Full Text] [Related]

  • 5. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J, Kathpalia P, Bushinsky DA, Favus MJ.
    J Clin Invest; 1998 May 15; 101(10):2223-32. PubMed ID: 9593778
    [Abstract] [Full Text] [Related]

  • 6. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK, Asplin JR, Culbertson CD, Granja I, Krieger NS, Bushinsky DA.
    Am J Physiol Renal Physiol; 2014 May 01; 306(9):F1081-7. PubMed ID: 24573387
    [Abstract] [Full Text] [Related]

  • 7. 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK, Asplin JR, Krieger NS, Culbertson CD, Asplin DM, Bushinsky DA.
    Am J Physiol Renal Physiol; 2013 Oct 15; 305(8):F1132-8. PubMed ID: 23926184
    [Abstract] [Full Text] [Related]

  • 8. Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
    Frick KK, Asplin JR, Favus MJ, Culbertson C, Krieger NS, Bushinsky DA.
    Am J Physiol Renal Physiol; 2013 Mar 15; 304(6):F718-26. PubMed ID: 23344574
    [Abstract] [Full Text] [Related]

  • 9. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.
    Krieger NS, Stathopoulos VM, Bushinsky DA.
    Am J Physiol; 1996 Jul 15; 271(1 Pt 1):C130-5. PubMed ID: 8760038
    [Abstract] [Full Text] [Related]

  • 10. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.
    Yao JJ, Bai S, Karnauskas AJ, Bushinsky DA, Favus MJ.
    J Am Soc Nephrol; 2005 May 15; 16(5):1300-8. PubMed ID: 15788476
    [Abstract] [Full Text] [Related]

  • 11. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease.
    Hoopes RR, Reid R, Sen S, Szpirer C, Dixon P, Pannett AA, Thakker RV, Bushinsky DA, Scheinman SJ.
    J Am Soc Nephrol; 2003 Jul 15; 14(7):1844-50. PubMed ID: 12819244
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification.
    Fu B, Wang H, Wang J, Barouhas I, Liu W, Shuboy A, Bushinsky DA, Zhou D, Favus MJ.
    PLoS One; 2013 Jul 15; 8(4):e61423. PubMed ID: 23620751
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.
    Frick KK, Krieger NS, Bushinsky DA.
    Curr Opin Nephrol Hypertens; 2015 Jul 15; 24(4):336-44. PubMed ID: 26050120
    [Abstract] [Full Text] [Related]

  • 16. The relation between bone and stone formation.
    Krieger NS, Bushinsky DA.
    Calcif Tissue Int; 2013 Oct 15; 93(4):374-81. PubMed ID: 23247537
    [Abstract] [Full Text] [Related]

  • 17. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
    Ng AH, Frick KK, Krieger NS, Asplin JR, Cohen-McFarlane M, Culbertson CD, Kyker-Snowman K, Grynpas MD, Bushinsky DA.
    Calcif Tissue Int; 2014 May 15; 94(5):531-43. PubMed ID: 24481706
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-delivered microRNA targeting the vitamin D receptor reduces intracellular Ca²⁺ concentrations by regulating the expression of Ca²⁺-transport proteins in renal epithelial cells.
    Xi Q, Wang S, Ye Z, Liu J, Yu X, Zhu Z, Su S, Bai J, Li C.
    BJU Int; 2011 Apr 15; 107(8):1314-9. PubMed ID: 20553254
    [Abstract] [Full Text] [Related]

  • 19. Does crystal deposition in genetic hypercalciuric rat kidney tissue share similarities with bone formation?
    Jia Z, Wang S, Tang J, He D, Cui L, Liu Z, Guo B, Huang L, Lu Y, Hu H.
    Urology; 2014 Feb 15; 83(2):509.e7-14. PubMed ID: 24468523
    [Abstract] [Full Text] [Related]

  • 20. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA, Neumann KJ, Asplin J, Krieger NS.
    Kidney Int; 1999 Jan 15; 55(1):234-43. PubMed ID: 9893132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.